Oncology Therapy Market Set to Surge: Breakthrough Treatments and Rising Cancer Cases Drive Global Growth 2025 | Leading key players - Amgen Inc., AstraZeneca, Bayer AG.

The Global Oncology Therapy Market size reached US$ 193.98 billion in 2024 and is expected to reach US$ 440.26 billion by 2033, growing at a compound annual growth rate (CAGR) of 9.6% during the forecast period of 2025-2033.

The Oncology Therapy Market, as examined by DataM Intelligence, provides a thorough industry overview enriched with detailed insights, historical data, and essential statistics. The report extensively explores market dynamics and competitive landscapes, featuring profiles of leading companies, their product offerings, pricing strategies, financials, growth plans, and geographic footprint.

Unlock exclusive insights with our detailed sample report (Corporate Email ID to get priority access) @ https://datamintelligence.com/download-sample/oncology-therapy-market?sz

The Oncology Therapy Market encompasses treatments aimed at preventing, diagnosing, and managing cancer. It includes chemotherapy, immunotherapy, targeted therapy, radiation therapy, and hormonal therapy. Driven by rising cancer prevalence, ongoing drug innovation, and increasing awareness, the market supports advancements in personalized medicine and biologics, contributing to improved patient outcomes and expanding therapeutic options across multiple cancer types worldwide.

Prominent Industry players in the Oncology Therapy Market

The prominent players in Oncology Therapy market research report are: Amgen Inc., AstraZeneca, Bayer AG, Merck & Co., Inc., Johnson & Johnson Services, Inc., F. Hoffmann-La Roche Ltd, Novartis AG, GSK plc, Eli Lilly and Company, Rigel Pharmaceuticals, Inc., and others.

The companies are primarily focusing on strategies such as new product launches to penetrate the fastest-growing emerging markets across the world.

Industry News

In April 2024, Johnson & Johnson secured FDA approval for CARVYKTI (ciltacabtagene autoleucel; cilta-cel) for treating adult patients with relapsed or refractory multiple myeloma who have undergone at least one prior line of therapy including a proteasome inhibitor and an immunomodulatory agent and are refractory to lenalidomide. This approval marks a major milestone, as CARVYKTI becomes the first and only BCMA-targeted therapy authorized for use in multiple myeloma as early as the first relapse, offering a new treatment avenue for patients with limited options.

In May 2024, Amgen received accelerated approval from the U.S. FDA for IMDELLTRA (tarlatamab-dlle), a new treatment option for adult patients with extensive-stage small cell lung cancer (ES-SCLC) who have experienced disease progression following platinum-based chemotherapy. The approval is based on promising clinical data, particularly the observed response rate and duration of response (DoR). Continued approval will depend on the results of ongoing confirmatory trials to further establish clinical benefit.

Speak to Our Senior Analyst and Get Customization in the report as per your requirements @ https://datamintelligence.com/customize/oncology-therapy-market

Market Segments

By Therapy: Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy, Radiation Therapy, Others.

By Application: Breast Cancer, Lung Cancer, Blood Cancer, Prostate Cancer, Colorectal Cancer, Stomach Cancer, Liver Cancer, Esophageal Cancer, Cervical Cancer, Ovarian Cancer, Bladder Cancer, Head and Neck Cancer, Skin Cancer (Melanoma), Pancreatic Cancer, Kidney Cancer, Others.

By End-User: Hospitals, Cancer Research Centers, Specialty Clinics, Others.

The Oncology Therapy industry is undergoing swift expansion, fueled by breakthroughs in medical technology, growing demand for cutting-edge therapies, and an increasing emphasis on patient-centric care. As the sector advances, in-depth market analysis is essential to track evolving trends, regulatory developments, and new opportunities.

Regions Covered:

The global Oncology Therapy Market report focuses on six major regions: North America, South America, Europe, Asia Pacific, the Middle East, and Africa.

☞ North America - US, Canada, Mexico

☞ Europe- Germany, Russia, UK, France, Italy, Rest of Europe

☞ Asia Pacific- China, India, Japan, Australia, Rest of Asia Pacific

☞ South America- Brazil, Argentina, Colombia, Rest of South America

☞ Middle East and Africa- Saudi Arabia, UAE, Oman, Bahrain, Qatar, Kuwait, Israel

FAQs:

✒ What is driving the growth of the Oncology Therapy Market?
✒ Who are the prominent players in the Oncology Therapy Market?
✒ How is the regulatory landscape affecting the Oncology Therapy Market?
✒ What regions are expected to see the highest growth?
✒ What are the key challenges faced by the Oncology Therapy Market?

Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription

Looking for Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=oncology-therapy-market?sz

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.